Clinical Trial Update: A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) [Phase 1, Phase 2]

View source ↗

Summary

A combination trial of epacadostat with pembrolizumab and chemotherapy in advanced or metastatic solid tumors has completed Phase 1/2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Epacadostat (epacadostat)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Incyte Corporation | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-07